Revvity (RVTY)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
$112.08-0.77%
Close 2026-07-07 · 1-day change
Reading RVTY? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track RVTY free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
Reading RVTY? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track RVTY free→QuarterlyIQ Insights · RVTY
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 2,902.4 | 2,856.1 | 2,755.0 | 3,311.8 | 3,827.8 | 3,782.7 | — | 2,883.7 | 2,778.0 | 2,257.0 | 2,115.5 | 2,237.2 | 2,237.2 | 2,166.2 | 2,115.2 | 1,921.3 | 1,704.3 |
| Total Revenues | — | — | — | 3,311.8 | 3,827.8 | 3,782.7 | — | 2,883.7 | 2,778.0 | 2,257.0 | 2,115.5 | 2,237.2 | 2,237.2 | 2,166.2 | 2,115.2 | 1,921.3 | 1,704.3 |
| Cost of Revenues | — | — | — | — | — | — | — | — | 1,437.1 | — | — | — | — | — | — | — | 945.7 |
| Gross Profit | — | — | — | 1,989.8 | 2,434.0 | 2,109.9 | — | 1,396.1 | 1,340.9 | 1,073.0 | 1,013.4 | 1,004.6 | 1,004.6 | 977.0 | 963.2 | 850.6 | — |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 996.1 | 991.9 | 994.1 | 1,022.6 | 975.2 | 716.5 | — | 815.3 | 811.9 | 616.2 | 600.9 | 659.3 | 659.3 | 585.9 | 632.7 | 627.2 | 490.7 |
| R&D Expenses | 220.1 | 215.8 | 196.8 | 216.6 | 200.3 | 146.4 | — | 189.3 | 194.0 | 139.4 | 124.3 | 121.1 | 121.1 | 133.0 | 132.6 | 115.8 | 95.4 |
| Operating Income | 360.3 | 356.6 | 346.7 | 300.6 | 1,258.5 | 867.3 | — | 362.0 | 323.9 | 304.8 | 283.1 | 210.7 | 210.7 | 217.4 | 98.5 | 91.1 | 153.6 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | — | — | — | — | 49.7 | — | 63.6 | 67.0 | 43.9 | 41.5 | 36.3 | 36.3 | 49.9 | 45.8 | 24.8 | — |
| Interest & Investment Income | 27.3 | 31.1 | 73.2 | 72.1 | 2.2 | 1.0 | — | 1.5 | 1.1 | 2.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 1.9 | — |
| Net Interest Expenses | — | — | — | — | — | 48.7 | — | 62.1 | 65.8 | 41.4 | 40.8 | 35.6 | 35.6 | 49.3 | 45.0 | 22.9 | — |
| Other Non-Operating Income / Expenses | (94.4) | (88.4) | (30.6) | (117.6) | (54.9) | (67.2) | — | (124.8) | (66.2) | (8.1) | (39.0) | (41.1) | (41.1) | (64.1) | (48.0) | (26.8) | — |
| Asset Writedown | — | 4.8 | 22.8 | 0.0 | 3.9 | 7.9 | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 265.9 | 268.3 | 316.1 | 651.8 | 1,203.6 | 906.4 | — | 237.1 | 257.7 | 296.7 | 244.1 | 169.6 | 169.6 | 153.3 | 50.6 | 64.4 | 162.0 |
| Income Tax Expense | 26.8 | 28.4 | 33.1 | 3.5 | 314.1 | 169.5 | — | 9.4 | 20.2 | 139.8 | 28.4 | 8.4 | 8.4 | (14.6) | (17.9) | 63.2 | 26.1 |
| Net Income | |||||||||||||||||
| Net Income | 239.7 | 241.2 | 270.4 | 693.1 | 943.2 | 727.9 | — | 227.6 | 237.9 | 292.6 | 234.3 | 157.8 | 157.8 | 167.2 | 69.9 | 7.7 | 383.9 |
| Per Share | |||||||||||||||||
| Basic EPS | 2.14 | 2.07 | 2.21 | 5.56 | 8.12 | 6.52 | — | 2.06 | 2.15 | 2.67 | 2.14 | 1.40 | 1.40 | 1.49 | 0.61 | 0.07 | 3.28 |
| Diluted EPS | 2.14 | 2.07 | 2.20 | 5.55 | 8.08 | 6.49 | — | 2.04 | 2.13 | 2.64 | 2.12 | 1.39 | 1.39 | 1.47 | 0.61 | 0.07 | 3.25 |
| Revenue per Share | 25.94 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | 0.28 | 0.28 | 0.28 | 0.28 | — | 0.28 | — | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | — |
| Basic Weighted Avg Shares | 111.9 | 116.5 | 122.8 | 124.7 | 116.2 | 111.5 | — | 110.8 | 110.6 | 109.9 | 109.5 | 112.6 | 112.6 | 112.3 | 113.7 | 113.0 | — |
| Diluted Weighted Avg Shares | 111.9 | 116.6 | 122.8 | 124.8 | 116.7 | 112.1 | — | 111.5 | 111.5 | 110.9 | 110.3 | 113.7 | 113.7 | 113.5 | 114.9 | 113.9 | — |
| Payout Ratio | 13.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | |||||||||||||||||
| EBITDA | — | 762.0 | 774.6 | 732.3 | 1,569.9 | 1,068.9 | — | 576.0 | 504.5 | 409.8 | 383.0 | 327.5 | 327.5 | 345.9 | 225.4 | 202.0 | 242.8 |
| EBIT | 360.3 | 356.6 | 346.7 | 300.6 | 1,258.5 | 867.3 | — | 362.0 | 323.9 | 304.8 | 283.1 | 210.7 | 210.7 | 217.4 | 98.5 | 91.1 | 153.6 |
| Effective Tax Rate | 10.1% | 10.6% | 10.5% | 0.5% | 26.1% | 18.7% | — | 4.0% | 7.8% | 47.1% | 11.6% | 5.0% | 5.0% | -9.5% | -35.3% | 98.2% | 16.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.